NO980936L - Pentacykliske forbindelser, mellomprodukter, fremgangsmÕter, preparater og metoder - Google Patents
Pentacykliske forbindelser, mellomprodukter, fremgangsmÕter, preparater og metoderInfo
- Publication number
- NO980936L NO980936L NO980936A NO980936A NO980936L NO 980936 L NO980936 L NO 980936L NO 980936 A NO980936 A NO 980936A NO 980936 A NO980936 A NO 980936A NO 980936 L NO980936 L NO 980936L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- compounds
- processes
- pyrrolidinyl
- methods
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 4
- 239000000543 intermediate Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- -1 2-oxo-1-piperidinyl Chemical group 0.000 abstract 6
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/18—Ring systems of four or more rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- C07F7/1872—Preparation; Treatments not provided for in C07F7/20
- C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Hydrogenated Pyridines (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Mechanical Pencils And Projecting And Retracting Systems Therefor, And Multi-System Writing Instruments (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US349695P | 1995-09-08 | 1995-09-08 | |
PCT/US1996/013778 WO1997009044A1 (en) | 1995-09-08 | 1996-08-26 | Pentacyclic compounds, intermediates, processes, compositions, and methods |
Publications (2)
Publication Number | Publication Date |
---|---|
NO980936D0 NO980936D0 (no) | 1998-03-04 |
NO980936L true NO980936L (no) | 1998-05-07 |
Family
ID=21706148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO980936A NO980936L (no) | 1995-09-08 | 1998-03-04 | Pentacykliske forbindelser, mellomprodukter, fremgangsmÕter, preparater og metoder |
Country Status (25)
Country | Link |
---|---|
US (3) | US5726186A (pt) |
EP (1) | EP0761669B1 (pt) |
JP (1) | JP3688299B2 (pt) |
KR (1) | KR19990044422A (pt) |
CN (1) | CN1201392A (pt) |
AT (1) | ATE197712T1 (pt) |
AU (1) | AU705454B2 (pt) |
BR (1) | BR9610356A (pt) |
CA (1) | CA2230974A1 (pt) |
CZ (1) | CZ286236B6 (pt) |
DE (1) | DE69611015T2 (pt) |
DK (1) | DK0761669T3 (pt) |
EA (1) | EA001649B1 (pt) |
ES (1) | ES2152496T3 (pt) |
GR (1) | GR3035253T3 (pt) |
HU (1) | HUP9802213A3 (pt) |
IL (1) | IL123560A (pt) |
MX (1) | MX9801734A (pt) |
NO (1) | NO980936L (pt) |
NZ (1) | NZ318183A (pt) |
PL (1) | PL325479A1 (pt) |
PT (1) | PT761669E (pt) |
SI (1) | SI0761669T1 (pt) |
TR (1) | TR199800387T1 (pt) |
WO (1) | WO1997009044A1 (pt) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5811447A (en) | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6251920B1 (en) | 1993-05-13 | 2001-06-26 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies |
US6491938B2 (en) | 1993-05-13 | 2002-12-10 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
AU6277396A (en) * | 1995-06-07 | 1996-12-30 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
AR021719A1 (es) * | 1998-12-18 | 2002-07-31 | Schering Corp | Composicion farmaceutica oral antiestrogenica. |
US7105679B2 (en) | 2001-12-19 | 2006-09-12 | Kanojia Ramesh M | Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators |
US7329654B2 (en) * | 2001-12-19 | 2008-02-12 | Janssen Pharmaceutica N.V. | Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators |
JP2005538091A (ja) | 2002-07-24 | 2005-12-15 | イーライ・リリー・アンド・カンパニー | ジヒドロ−ベンゾ[b,e]オキセピンに基づく選択的エストロゲン受容体調節物質、組成物および方法 |
EP1551822B1 (en) | 2002-07-24 | 2006-12-20 | Eli Lilly And Company | Pentacyclic oxepines and derivatives thereof, process for their preparation and pharmaceutical compositions containing them |
JP3887588B2 (ja) * | 2002-08-30 | 2007-02-28 | 株式会社リガク | X線回折による応力測定法 |
US7119206B2 (en) | 2002-09-25 | 2006-10-10 | Eli Lilly And Company | Derivative of dihydro-dibenzo (a) anthracenes and their use as selective estrogen receptor modulators |
US6894061B2 (en) | 2002-12-04 | 2005-05-17 | Wyeth | Substituted dihydrophenanthridinesulfonamides |
US7074779B2 (en) * | 2003-07-02 | 2006-07-11 | Ortho-Mcneil Pharmaceutical, Inc. | Estrieno[3,2-b]/[3,4-c]pyrrole derivatives useful as modulators of the estrogen receptors |
WO2005073244A1 (en) * | 2004-01-22 | 2005-08-11 | Eli Lilly And Company | Selective estrogen receptor modulators |
JP4909086B2 (ja) * | 2004-01-22 | 2012-04-04 | イーライ リリー アンド カンパニー | 血管運動性症候の治療のための選択的エストロゲン受容体モジュレーター |
CN1910167B (zh) * | 2004-01-22 | 2011-08-10 | 伊莱利利公司 | 用于治疗血管舒缩症状的选择性雌激素受体调节剂 |
MX2012014579A (es) | 2010-06-16 | 2013-05-22 | Endorech Inc | Procedimientos de tratamiento o pevencion de enfermedades relacionadas con estrogenos. |
KR102021162B1 (ko) | 2011-11-01 | 2019-09-11 | 메르크 파텐트 게엠베하 | 유기 전계발광 소자 |
US8829993B2 (en) | 2012-10-30 | 2014-09-09 | Eta Devices, Inc. | Linearization circuits and methods for multilevel power amplifier systems |
CN109678878A (zh) * | 2019-02-27 | 2019-04-26 | 陕西科技大学 | 一种苯并噻吩并香豆素类化合物及其合成方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2884427A (en) * | 1958-01-22 | 1959-04-28 | Oliver H Emerson | Synthesis of coumestrol and its esters |
US2987398A (en) * | 1958-05-12 | 1961-06-06 | Emanuel M Bickoff | Coumestrol ethers and use thereof |
US3912740A (en) * | 1974-02-28 | 1975-10-14 | Us Health | Method for the preparation of oxygenated benzo{8 c{9 phenanthridine compounds |
US4230862A (en) * | 1975-10-28 | 1980-10-28 | Eli Lilly And Company | Antifertility compounds |
US4418068A (en) * | 1981-04-03 | 1983-11-29 | Eli Lilly And Company | Antiestrogenic and antiandrugenic benzothiophenes |
US4659671A (en) * | 1983-07-01 | 1987-04-21 | Massachusetts Institute Of Technology | Enzymatic separation of racemic mixtures of hydroxy compounds |
CA2054569A1 (en) * | 1990-11-07 | 1992-05-08 | Masanobu Suzuki | Process for preparing benzo¬c|phenanthridinium derivatives, and novel compounds prepared by said process |
US5147880A (en) * | 1991-07-22 | 1992-09-15 | Eli Lilly And Company | Benzo[a]fluorene compounds |
TW366342B (en) * | 1992-07-28 | 1999-08-11 | Lilly Co Eli | The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss |
US5336687A (en) * | 1993-08-04 | 1994-08-09 | American Home Products Corporation | Inhibition of bone loss by 4-aryloxy-5-hydroxy-2(5H)-furanones |
-
1996
- 1996-08-13 US US08/696,279 patent/US5726186A/en not_active Expired - Fee Related
- 1996-08-26 CA CA002230974A patent/CA2230974A1/en not_active Abandoned
- 1996-08-26 WO PCT/US1996/013778 patent/WO1997009044A1/en not_active Application Discontinuation
- 1996-08-26 KR KR1019980701667A patent/KR19990044422A/ko not_active Application Discontinuation
- 1996-08-26 NZ NZ318183A patent/NZ318183A/en unknown
- 1996-08-26 PL PL96325479A patent/PL325479A1/xx unknown
- 1996-08-26 IL IL12356096A patent/IL123560A/en not_active IP Right Cessation
- 1996-08-26 JP JP51125797A patent/JP3688299B2/ja not_active Expired - Fee Related
- 1996-08-26 TR TR1998/00387T patent/TR199800387T1/xx unknown
- 1996-08-26 AU AU69590/96A patent/AU705454B2/en not_active Ceased
- 1996-08-26 BR BR9610356A patent/BR9610356A/pt active Search and Examination
- 1996-08-26 HU HU9802213A patent/HUP9802213A3/hu unknown
- 1996-08-26 MX MX9801734A patent/MX9801734A/es not_active IP Right Cessation
- 1996-08-26 CN CN96198083A patent/CN1201392A/zh active Pending
- 1996-08-26 CZ CZ1998678A patent/CZ286236B6/cs not_active IP Right Cessation
- 1996-08-26 EA EA199800278A patent/EA001649B1/ru not_active IP Right Cessation
- 1996-09-02 SI SI9630281T patent/SI0761669T1/xx unknown
- 1996-09-02 EP EP96306351A patent/EP0761669B1/en not_active Expired - Lifetime
- 1996-09-02 AT AT96306351T patent/ATE197712T1/de not_active IP Right Cessation
- 1996-09-02 DK DK96306351T patent/DK0761669T3/da active
- 1996-09-02 PT PT96306351T patent/PT761669E/pt unknown
- 1996-09-02 DE DE69611015T patent/DE69611015T2/de not_active Expired - Fee Related
- 1996-09-02 ES ES96306351T patent/ES2152496T3/es not_active Expired - Lifetime
-
1997
- 1997-06-19 US US08/878,799 patent/US6004971A/en not_active Expired - Fee Related
-
1998
- 1998-03-04 NO NO980936A patent/NO980936L/no not_active Application Discontinuation
-
1999
- 1999-11-09 US US09/436,743 patent/US6133288A/en not_active Expired - Fee Related
-
2001
- 2001-01-17 GR GR20010400073T patent/GR3035253T3/el not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO980936L (no) | Pentacykliske forbindelser, mellomprodukter, fremgangsmÕter, preparater og metoder | |
YU61595A (sh) | Nova naftilna jedinjenja, njihovi intermedijeri farmaceutske kompozicije, i postupci za dobijanje tih jedinjenja | |
YU11496A (sh) | Naftilna jedinjenja, njihove farmaceutske formulacije i intermedijari i postupak za njihovo dobijanje | |
FI843422A0 (fi) | Tiazolidinderivat, deras framstaellning och sammansaettningar innehaollande dem. | |
FI783456A (fi) | 1,9-dihydroxioktahydrofenantrener och mellanprodukter foer dem | |
DZ1694A1 (fr) | "n-(2-Aminoethyl)-benzothialozones". | |
TR199800132T1 (xx) | Naftil ve dihidronaftil ara �r�nler, bile�ikler, kompozisyonlar ve bunlar�n �retimi i�in y�ntemler. | |
DE69532079D1 (de) | Benzofuranverbindungen, präparate und verfahren | |
MX16728A (es) | Derivados de piperidina 1-ariletil-3-substituidos y procedimiento para su preparacion | |
YU34396A (sh) | Farmaceutske smeše korisne za minimiziranje oštećenja kostiju | |
YU9199A (en) | Naphtyl compounds, intermediates, compositions, and metods for use | |
KR910009638A (ko) | 폴리엔 마크로라이드 유도체 | |
SE7506058L (sv) | Forfarande for framstellning av 1h-tetrazolderivat med terapeutisk verkan | |
YU34296A (en) | Use a compounds for medicament obtaining and pharmaceutical composition thereof | |
DE69711527D1 (de) | Benzofluorenverbindungen, Zwischenverbindungen, Zusammensetzungen und Verfahren | |
ATE22284T1 (de) | 2-aminomethyl-6-sulfamoylphenolderivate, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen. | |
CA2210579A1 (en) | Benzene derivatives | |
ATE348824T1 (de) | Pentacyclische oxepine und derivate davon, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten | |
RS49886B (sr) | Benzotiofenska jedinjenja, intermedijari, kompozicije i metode | |
JPS545918A (en) | Ampholytic ionic polymerizable compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |